Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation.
Venditti A, Maurillo L, Buccisano F, Del Poeta G, Mazzone C, Tamburini A, Del Principe MI, Consalvo MI, De Fabritiis P, Cudillo L, Picardi A, Franchi A, Lo-Coco F, Amadori S. Venditti A, et al. Among authors: amadori s. Leukemia. 2003 Nov;17(11):2178-82. doi: 10.1038/sj.leu.2403138. Leukemia. 2003. PMID: 14576731 Clinical Trial.
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.
Del Principe MI, Del Poeta G, Maurillo L, Buccisano F, Venditti A, Tamburini A, Bruno A, Cox MC, Suppo G, Tendas A, Giannì L, Postorino M, Masi M, Del Principe D, Amadori S. Del Principe MI, et al. Among authors: amadori s. Br J Haematol. 2003 Jun;121(5):730-8. doi: 10.1046/j.1365-2141.2003.04343.x. Br J Haematol. 2003. PMID: 12780787 Free article.
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Picardi A, Fabritiis Pd Pd, Cudillo L, Dentamaro T, Cupelli L, Ballatore G, Venditti A, Caravita T, Cristina Cox M, Catalano G, Amadori S. Picardi A, et al. Among authors: amadori s. Hematol J. 2004;5(1):24-31. doi: 10.1038/sj.thj.6200357. Hematol J. 2004. PMID: 14745426 Clinical Trial.
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias.
Buccisano F, Rossi FM, Venditti A, Del Poeta G, Cox MC, Abbruzzese E, Rupolo M, Berretta M, Degan M, Russo S, Tamburini A, Maurillo L, Del Principe MI, Postorino M, Amadori S, Gattei V. Buccisano F, et al. Among authors: amadori s. Br J Haematol. 2004 Apr;125(2):203-12. doi: 10.1111/j.1365-2141.2004.04883.x. Br J Haematol. 2004. PMID: 15059143 Free article.
427 results